Current Cardiovascular Drugs
- Publisher's listprice EUR 85.55
-
35 481 Ft (33 792 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 7 096 Ft off)
- Discounted price 28 385 Ft (27 034 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
35 481 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 3
- Publisher Current Medicine Group
- Date of Publication 1 May 2000
- Number of Volumes 1 pieces, Book
- ISBN 9781573401357
- Binding Paperback
- No. of pages342 pages
- Size 280x216 mm
- Weight 886 g
- Language English
- Illustrations VIII, 342 p. 0
Categories
Long description:
The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
MoreTable of Contents:
How to Use This Book.- Alpha-Adrenergic Blockers (Peripherally Acting Antihypertensive Agents).- Alpha2-Adrenergic Agonists (Centrally Acting Antihypertensive Agents).- Angiotensin-Converting Enzyme Inhibitors.- Angiotensin-II Receptor Blockers.- Antiarrhythmic Agents.- Antithrombotic Therapy.- Beta-Adrenergic Blockers.- Calcium Antagonists.- Diuretics.- Inotropic and Vasopressor Agents.- Lipid-Lowering Drugs.- Neuronal and Ganglionic Blockers.- Vasodilators (Other Agents and Drug Classes).- Drugs in Development: New Agents, New Classes, New Indications.
More
The Rescue: The True Story of the SAS Mission to Save Hostages from the Taliban
9 555 HUF
8 122 HUF
Dirk Gentlys Holistische Detektei - Ein zu kurzer Löffel: Bd. 2
7 050 HUF
6 698 HUF
Richard Serra: La Mormaire
24 622 HUF
22 653 HUF
